A randomized multicenter double-blind clinical trial to evaluate the efficacy and safety of 10mg alfuzosin in the treatment of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) in recently-diagnosed and/or newly-symptomatic alpha-blocker naive patients

Trial Profile

A randomized multicenter double-blind clinical trial to evaluate the efficacy and safety of 10mg alfuzosin in the treatment of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) in recently-diagnosed and/or newly-symptomatic alpha-blocker naive patients

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jan 2010

At a glance

  • Drugs Alfuzosin (Primary)
  • Indications Prostatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Dec 2008 Results have been published in the New England Journal of Medicine.
    • 12 Mar 2008 Status changed from in progress to completed. Updated from ClinicalTrials.gov.
    • 11 Oct 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top